Antitrust & Competition Life Sciences Quarterly Update - Q2 2023 | Goodwin
The second quarter saw significant enforcement and dealmaking in the life sciences space. The Federal Trade Commission (FTC) announced its attempt to block Amgen/Horizon, the first such...
Source: jdsupra.com